How Bristol Myers Squibb Is Accelerating Drug Development With AI - Ep. 264
Update: 2025-07-09
Description
Greg Meyers, chief digital and technology officer at Bristol Myers Squibb, explains how AI is transforming pharmaceutical research from hypothesis-driven hunches to data-driven discoveries. Learn how the company is using computational chemistry to engineer breakthrough therapies like a sickle cell treatment heading to human trials, and why they built internal AI tools for 25,000+ employees. Learn more at ai-podcast.nvidia.com.
Comments
In Channel
Download from Google Play
Download from App Store
United States00:00
00:00
x
